{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:58:16Z","timestamp":1782928696521,"version":"3.54.5"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The long-term impact of SARS-CoV-2 infection on inflammatory dermatoses remains incompletely defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the association between COVID-19 infection and a broad range of inflammatory dermatoses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cohort study, electronic health-record data were analysed for 204 241 patients seen at a tertiary medical centre between March 2020 and May 2023, including 22 368 with confirmed COVID-19 and 181 873 controls with negative testing. Diagnoses of 16 inflammatory dermatoses were extracted from standardized documentation fields and verified diagnostic codes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Elevated risks were observed for atopic dermatitis [incidence rate ratio (IRR) 1.35, 95% confidence interval (CI) 1.25\u20131.46; P &amp;lt; 0.001], acne vulgaris (IRR 1.53, 95% CI 1.17\u20131.98; P = 0.002), rosacea (IRR 2.41, 95% CI 1.53\u20133.66; P &amp;lt; 0.001), alopecia areata (IRR 2.39, 95% CI 1.44\u20133.80; P &amp;lt; 0.001) and seborrhoeic dermatitis (IRR 1.74; 95% CI 1.29\u20132.30; P &amp;lt; 0.001). No significant associations were observed for psoriasis, hidradenitis suppurativa, lupus erythematosus, pemphigus or bullous pemphigoid.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>COVID-19 infection emerged as a novel risk factor for several inflammatory dermatoses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ced\/llag054","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:38:50Z","timestamp":1769603930000},"page":"1041-1045","source":"Crossref","is-referenced-by-count":1,"title":["Risk of inflammatory dermatoses following COVID-19 infection: a cohort study of 204 241 patients"],"prefix":"10.1093","volume":"51","author":[{"given":"Danielle","family":"Bar","sequence":"first","affiliation":[{"name":"Department of Dermatology, Gray Faculty of Medical and Health Sciences, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilia","family":"Beberashvili","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gray Faculty of Medical and Health Sciences, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"2026052522572295900_llag054-B1","doi-asserted-by":"crossref","first-page":"102314","DOI":"10.1016\/j.tmaid.2022.102314","article-title":"Systematic review of COVID-19 and autoimmune thyroiditis","volume":"47","author":"Tutal","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"2026052522572295900_llag054-B2","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1007\/s00415-022-11050-w","article-title":"Neuroimmune disorders in COVID-19","volume":"269","author":"Ari\u00f1o","year":"2022","journal-title":"J Neurol"},{"key":"2026052522572295900_llag054-B3","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.3390\/cells10123592","article-title":"New onset of autoimmune diseases following COVID-19 diagnosis","volume":"10","author":"Gracia-Ramos","year":"2021","journal-title":"Cells"},{"key":"2026052522572295900_llag054-B4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/v11080762","article-title":"Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms","volume":"11","author":"Smatti","year":"2019","journal-title":"Viruses"},{"key":"2026052522572295900_llag054-B5","doi-asserted-by":"crossref","first-page":"102695","DOI":"10.1016\/j.autrev.2020.102695","article-title":"SARS-CoV-2, the autoimmune virus","volume":"19","author":"Halpert","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2026052522572295900_llag054-B6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J Med Virol"},{"key":"2026052522572295900_llag054-B7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol J"},{"key":"2026052522572295900_llag054-B8","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1007\/s10067-020-05376-x","article-title":"The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach","volume":"39","author":"Najafi","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2026052522572295900_llag054-B9","doi-asserted-by":"crossref","first-page":"155873","DOI":"10.1016\/j.cyto.2022.155873","article-title":"SARS-CoV-2 triggering autoimmune diseases","volume":"154","author":"Mobasheri","year":"2022","journal-title":"Cytokine"},{"key":"2026052522572295900_llag054-B10","doi-asserted-by":"crossref","first-page":"101783","DOI":"10.1016\/j.eclinm.2022.101783","article-title":"Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study","volume":"56","author":"Chang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026052522572295900_llag054-B11","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jamadermatol.2024.4233","article-title":"Long-term risk of autoimmune and autoinflammatory connective tissue disorders following COVID-19","volume":"160","author":"Heo","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2026052522572295900_llag054-B12","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1038\/s41467-024-50656-8","article-title":"Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study","volume":"15","author":"Jung","year":"2024","journal-title":"Nat Commun"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag054\/66634188\/llag054.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/6\/1041\/66634188\/llag054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/6\/1041\/66634188\/llag054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:57:28Z","timestamp":1779764248000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/6\/1041\/8444745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,1,30]]},"published-print":{"date-parts":[[2026,5,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llag054","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,1,30]]}}}